Earnings Call · Q3 FY2022·2022-10-27

Q3 22EPS -14.49%·Rev n/aQ2 22EPS -49.26%·Rev n/aQ1 22EPS -2.05%·Rev n/aQ4 21EPS -34.13%·Rev n/a⚠ consensus missing

ALNYLAM PHARMACEUTICALS, INC. ALNY

Christine Lindenboom — Senior Vice President of Investor Relations and Corporate Communications

Yvonne Greenstreet — Chief Executive Officer

Tolga Tanguler — Chief Commercial Officer

Akshay Vaishnaw — President

Jeff Poulton — Chief Financial Officer

−3.5%1d on move date−3.0% vs SPY3d+3.1%5d+6.6%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ALNY calls or request research access.

More ALNY calls Browse calls Request research access